Your browser doesn't support javascript.
loading
Tratamiento farmacológico o quirúrgico del paciente con sobrepeso u obesidad / Statement about the medical and surgical treatment of overweight and obesity
Carrasco, Fernando; Manrique, Mónica; de la Maza, María Pía; Moreno, Manuel; Albala, Cecilia; García, Jaime; Díaz, Jaime; Liberman, Claudio.
Affiliation
  • Carrasco, Fernando; Universidad de Chile. Facultad de Medicina. Departamento de Nutrición. Santiago. CL
  • Manrique, Mónica; Instituto Médico Nutramed. Santiago. CL
  • de la Maza, María Pía; Universidad de Chile. Instituto de Nutrición y Tecnología de los Alimentos. Santiago. CL
  • Moreno, Manuel; Pontificia Universidad Católica de Chile. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
  • Albala, Cecilia; Instituto Médico Nutramed. Santiago. CL
  • García, Jaime; Centro Médico CAPREDENA. Santiago. CL
  • Díaz, Jaime; Hospital San Juan de Dios. Unidad de Diabetes. Santiago. CL
  • Liberman, Claudio; Hospital Clínico de la Universidad de Chile. Departamento de Endocrinología. Santiago. CL
Rev. méd. Chile ; 137(7): 972-981, jul. 2009. tab
Article in Es | LILACS | ID: lil-527138
Responsible library: BR1.1
ABSTRACT
This is an updated review of the available treatments for obesity, which can be used when lifestyles modifications fail. Using the available information and the experience of the members of this advisory group, a recommendation is given about the most useful treatments, according to the severity of obesity and its complications. With regards to pharmacological treatments, only sibutramine and orlistat are approved on a worldwide basis for the treatment of obesity. These medications achieve a 10 percent higher weight reduction than lifestyles modification. A third medication, rimonobant, is also more effective than lifestyles modifications, but it was withdrawn due to psychological safety issues. The indications for surgical treatment and a brief description of the available techniques, success rates and complications are outlined. Finally, the need to have followed up protocols for patients and the formation of multidisciplinary treatment teams is underscored.
Subject(s)
Key words
Full text: 1 Index: LILACS Main subject: Gastric Bypass / Anti-Obesity Agents / Obesity Type of study: Guideline Limits: Humans Language: Es Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2009 Type: Article
Full text: 1 Index: LILACS Main subject: Gastric Bypass / Anti-Obesity Agents / Obesity Type of study: Guideline Limits: Humans Language: Es Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2009 Type: Article